Evaluation of HS-20137 in Chinese Patients with Moderate-to-Severe Psoriasis: Results from a Phase 2, Randomized, Double-Blind Trial - Quiz - MDSpire

Evaluation of HS-20137 in Chinese Patients with Moderate-to-Severe Psoriasis: Results from a Phase 2, Randomized, Double-Blind Trial

  • By

  • Lin Cai

  • Xiaohua Wang

  • Litao Zhang

  • Guoqiang Zhang

  • Liming Wu

  • Baoqi Yang

  • Zudong Meng

  • Jihai Shi

  • Guangming Han

  • Aihua Wei

  • Shanshan Li

  • Yi Zhao

  • Juan Su

  • Nianjin Wei

  • Siying Liu

  • Ran Liu

  • Wei Liu

  • Min Fang

  • Xiaoqing Zhang

  • Jianzhong Zhang

  • March 22, 2026

  • 0 min

Share

Original Source(s)

Evaluation of HS-20137 in Chinese Patients with Moderate-to-Severe Psoriasis: Results from a Phase 2, Randomized, Double-Blind Trial

  • by Lin Cai, Xiaohua Wang, Litao Zhang, Guoqiang Zhang, Liming Wu, Baoqi Yang, Zudong Meng, Jihai Shi, Guangming Han, Aihua Wei, Shanshan Li, Yi Zhao, Juan Su, Nianjin Wei, Siying Liu, Ran Liu, Wei Liu, Min Fang, Xiaoqing Zhang, Jianzhong Zhang

  • March 22, 2026

Related Content

Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.